BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (“Sucampo” or the “Company”), (NASDAQ: SCMP), a global pharmaceutical company, today reported its consolidated financial results for the quarter and full year ended December 31, 2011.
For the full year 2011 Sucampo reported a net loss of $17.3 million, or $0.41 per diluted share, compared to a net loss of $2.8 million, or $0.07 per diluted share, for 2010. Sucampo reported net income of $2.7 million, or $0.06 per diluted share, for the fourth quarter compared to a net loss of $6.3 million, or $.15 per diluted share, for the same period in 2010.
